Literature DB >> 18483307

Heme oxygenase-1 inhibits breast cancer invasion via suppressing the expression of matrix metalloproteinase-9.

Cheng-Wei Lin1, Shing-Chun Shen, Wen-Chi Hou, Liang-Yo Yang, Yen-Chou Chen.   

Abstract

In the present study, we investigated the antitumor effects of the invasiveness and migration of heme oxygenase 1 (HO-1) in human breast carcinoma cells. 12-O-tetradecanoylphorbol-13-acetate (TPA)-induced matrix metalloproteinase-9 (MMP-9) enzyme activity and gene expression at both protein and mRNA levels were examined in human breast carcinoma cells (MCF-7 and MDA-MB-231), and the addition of the MMP-9 inhibitor, SB3CT, significantly suppressed TPA-induced invasion and migration according to the in vitro Transwell assay. Elevation of HO-1 gene expression by ferric protoporphyrin IX inhibited TPA-induced invasion of MCF-7 cells, which was blocked by adding the heme oxygenase inhibitor, tin protoporphyrin IX, or transfection of cells with HO-1 short hairpin RNA. MCF-7 cells overexpressing HO-1 (MCF-7/HO-1) were established in the present study, and TPA-induced MMP-9 gene expression, tumor invasion, and colony formation were significantly reduced in MCF-7/HO-1 cells, compared with those in Neo-transfected cells. Activation of protein kinase Calpha/extracellular signal-regulated kinases/AP-1 with stimulation of reactive oxygen species production was involved in TPA-induced invasion of MCF-7 cells, which was attenuated by HO-1 protein induced by ferric protoporphyrin IX or transfection of HO-1 expression vectors. Additionally, the addition of carbon monoxide, but not ferric ions, biliverdin, or bilirubin, inhibited TPA-induced invasion through suppressing MMP-9, extracellular signal-regulated kinases, and AP-1 activation stimulated by TPA. The beneficial role of HO-1 in blocking tumor invasion was first identified in this study.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18483307     DOI: 10.1158/1535-7163.MCT-07-2199

Source DB:  PubMed          Journal:  Mol Cancer Ther        ISSN: 1535-7163            Impact factor:   6.261


  46 in total

1.  Heme oxygenase promotes B-Raf-dependent melanosphere formation.

Authors:  Kimberly J Jasmer; Jie Hou; Philip Mannino; Jianlin Cheng; Mark Hannink
Journal:  Pigment Cell Melanoma Res       Date:  2020-07-09       Impact factor: 4.693

2.  PAD1 promotes epithelial-mesenchymal transition and metastasis in triple-negative breast cancer cells by regulating MEK1-ERK1/2-MMP2 signaling.

Authors:  Hao Qin; Xiaoqiu Liu; Fujun Li; Lixia Miao; Tingting Li; Boqun Xu; Xiaofei An; Aaron Muth; Paul R Thompson; Scott A Coonrod; Xuesen Zhang
Journal:  Cancer Lett       Date:  2017-08-24       Impact factor: 8.679

3.  The histone deacetylase inhibitor butyroyloxymethyl diethylphosphate (AN-7) protects normal cells against toxicity of anticancer agents while augmenting their anticancer activity.

Authors:  Nataly Tarasenko; Gania Kessler-Icekson; Pnina Boer; Aida Inbal; Hadassa Schlesinger; Don R Phillips; Suzanne M Cutts; Abraham Nudelman; Ada Rephaeli
Journal:  Invest New Drugs       Date:  2010-09-23       Impact factor: 3.850

4.  BMP-6 inhibits MMP-9 expression by regulating heme oxygenase-1 in MCF-7 breast cancer cells.

Authors:  Chuan Wang; Fen Hu; Shaocong Guo; Dong Mi; Wenwen Shen; Jie Zhang; Yuhuan Qiao; Tianhui Zhu; Shuang Yang
Journal:  J Cancer Res Clin Oncol       Date:  2010-12-07       Impact factor: 4.553

5.  Osteopontin increases heme oxygenase-1 expression and subsequently induces cell migration and invasion in glioma cells.

Authors:  Dah-Yuu Lu; Wei-Lan Yeh; Ssu-Ming Huang; Chih-Hsin Tang; Hsiao-Yun Lin; Shao-Jiun Chou
Journal:  Neuro Oncol       Date:  2012-10-16       Impact factor: 12.300

6.  The HER2- and heregulin β1 (HRG)-inducible TNFR superfamily member Fn14 promotes HRG-driven breast cancer cell migration, invasion, and MMP9 expression.

Authors:  Kaushal Asrani; Ruth A Keri; Rebeca Galisteo; Sharron A N Brown; Sarah J Morgan; Arundhati Ghosh; Nhan L Tran; Jeffrey A Winkles
Journal:  Mol Cancer Res       Date:  2013-02-01       Impact factor: 5.852

7.  Inhibition of fatty acid amide hydrolase activates Nrf2 signalling and induces heme oxygenase 1 transcription in breast cancer cells.

Authors:  H Li; J T Wood; K M Whitten; S K Vadivel; S Seng; A Makriyannis; H K Avraham
Journal:  Br J Pharmacol       Date:  2013-10       Impact factor: 8.739

8.  Transcriptome Analysis of Piperlongumine-Treated Human Pancreatic Cancer Cells Reveals Involvement of Oxidative Stress and Endoplasmic Reticulum Stress Pathways.

Authors:  Harsharan Dhillon; Sujan Mamidi; Phillip McClean; Katie M Reindl
Journal:  J Med Food       Date:  2016-04-27       Impact factor: 2.786

9.  The CO donor CORM-2 inhibits LPS-induced vascular cell adhesion molecule-1 expression and leukocyte adhesion in human rheumatoid synovial fibroblasts.

Authors:  Pei-Ling Chi; Yu-Chen Chuang; Yu-Wen Chen; Chih-Chung Lin; Li-Der Hsiao; Chuen-Mao Yang
Journal:  Br J Pharmacol       Date:  2014-06       Impact factor: 8.739

10.  Active site ring-opening of a thiirane moiety and picomolar inhibition of gelatinases.

Authors:  Christopher Forbes; Qicun Shi; Jed F Fisher; Mijoon Lee; Dusan Hesek; Leticia I Llarrull; Marta Toth; Michael Gossing; Rafael Fridman; Shahriar Mobashery
Journal:  Chem Biol Drug Des       Date:  2009-10-06       Impact factor: 2.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.